Skip to content
Medical Health Aged Care

RACGP welcomes Queensland meningococcal B vaccine announcement

Royal Australian College of GPs 2 mins read

The Royal Australian College of General Practitioners (RACGP) has warmly welcomed the Queensland Government making the meningococcal B vaccine free for all infants and children under the age of two, and adolescents aged 15 to 19 years.

Coming into effect next year, the vaccinations will form part of the routine childhood and school immunisation programs for eligible cohorts, as recommended by the Australian Technical Advisory Group on Immunisation, or ATAGI. The National Immunisation Program, or NIP, for infants and adolescents covers the ACWY strains of meningococcal. However, the B strain requires an additional self-funded immunisation for children of normal risk – at a cost of approximately $200 to 300 for the required two doses. South Australia is the only state that funds a vaccination program for meningococcal B for the broader population.

RACGP President Dr Nicole Higgins welcomed the announcement.

“This is great decision from the Queensland Government and one that will potentially save lives,” she said.

Meningococcal B must be taken seriously. This is a rare but terrible disease that without urgent care can result in death or disability. Just a few years ago, a two-year-old died from meningococcal B at my practice and it is something that you never forget. Many people may not realise that meningococcal serogroups B and W are currently responsible for most meningococcal disease in Australia. The B strain is the most common cause of invasive meningococcal disease in children, adolescents, and young adults.

“Between 1997 and 2016, it is estimated that 396 people died from meningococcal disease and 32% of those deaths happened to children aged less than five. It’s a dangerous disease for those who make it through too, 25% of people who get this disease end up with a disability.

“Families have a lot on their plate, and many parents and carers may think that their children are already immunised against this disease. It’s only when they check their children’s immunisation schedules that they realise they are not immunised against meningococcal B. Unfortunately, there just isn’t a high level of awareness in the community that a different vaccine is needed for meningococcal B and that is something I would like to see change because this disease is a killer.

“There is evidence that meningococcal B is emerging as a more common cause of death and one reason may be a result of widespread vaccination in the community against the other meningococcal strains. Meningococcal B must be a priority, so I applaud the Queensland Government for making this investment and encourage all families to take full advantage of the free jabs. Given high cost of living pressures, this announcement could not come at a better time.

“We join AMA Queensland in saying that we hope the federal Government takes note of this timely decision and adds the B strain vaccine to the National Immunisation Program so all young people across Australia are protected from this terrible disease.”

~ENDS

RACGP spokespeople are available for comment.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

Email: [email protected] (we will respond promptly to all requests for interview).

Follow us on Twitter: @RACGP and Facebook.

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

More from this category

  • Medical Health Aged Care
  • 09/12/2025
  • 05:30
Centre for Eye Research Australia

Australian scientists reveal new genetic risk for severe macular degeneration

Researchers and a person living with macular degeneration are available for interview in East Melbourne today. Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD). A new study, published today inNature Communications, reveals the specific genetic factors linked to the presence of reticular pseudodrusen - deposits which drive vision loss and are found on the retina of up to 60 per cent of people with advanced AMD. The research, led by the Centre for Eye Research Australia, WEHI and the University of Melbourne, offers a…

  • Medical Health Aged Care
  • 09/12/2025
  • 01:11
SoluPet Inc.

SoluPet Inc. (SoluPet) Announces Strategic Partnership with CHC Healthcare Group (CHC) to Advance Canine Cognitive Health in Asia

Partnership with CHC in Taiwan will pilot SoluPet’s flagship Neuronal Defense™ formulation through CHC’s veterinary and consumer-health ecosystem TORONTO–BUSINESS WIRE– SoluPet,the data and science-driven…

  • Contains:
  • Medical Health Aged Care
  • 09/12/2025
  • 00:11
AdvanCell

AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies

Thorium-228 (228Th) is the parent isotope and key starting material to produce the alpha-emitter Lead-212 (212Pb) The established capability to receive and process high-activity…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.